Prevention of the metabolic effects of 2-tetradecylglycidate by octanoic acid in the genetically diabetic mouse ()
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Biochemical Medicine
- Vol. 33 (1) , 104-109
- https://doi.org/10.1016/0006-2944(85)90132-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Metabolic control of prevention of nephropathy by 2-tetradecylglycidate in the diabetic mouse (db/db)Diabetes, 1982
- Early immunopathologic events in experimental diabetic nephropathy: A study in miceExperimental and Molecular Pathology, 1980
- Inhibition of fatty acid oxidation in normal and hypoxic perfused rat hearts by 2-tetradecylglycidic acidJournal of Molecular and Cellular Cardiology, 1979
- Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation SelectivelyDiabetes, 1979
- Carnitine and Its Role in Fatty Acid Metabolism* *Work reviewed from this laboratory was supported by grants A-1465 and A-1682 from the National Institutes of Health.Published by Elsevier ,1963
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951
- Intestinal Lymph as Pathway for Transport of Absorbed Fatty Acids of Different Chain LengthsAmerican Journal of Physiology-Legacy Content, 1951